secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vor Biopharma Inc. (VOR)
CIK:        0001817229
Form:       8-K
Filed at:   2024-12-27T23:59:59+00:00
Accession:  0001193125-24-285627
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 3.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vor Bio raises $55.6M in PIPE; extends cash runway to 2025 clinical data readouts
--------------------------------------------------------------------------------

- Private placement of 55.87M shares and warrants for 69.84M shares at combined $0.99425 price, gross proceeds ~$55.6M.
- New investor Reid Hoffman led; existing investor RA Capital participated; each gets one board seat and one observer seat.
- Updated Phase 1/2 VCAR33 ALLO data expected H1 2025; Phase 1/2a trem-cel+Mylotarg data H2 2025.
- Net proceeds to fund pipeline development and general corporate; warrant exercise could add $58.5M.
- Warrants exercisable at $0.838/share, expire 7 years from issuance; closing expected Dec 30, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1817229/000119312524285627/0001193125-24-285627-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1817229/000119312524285627/d865206d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-285627

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer